New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

More Momentum for Male Birth Control

The newest form of male birth control just passed safety and tolerability tests when used daily for a month.

Male Contraceptive Pill / Image: Pixabay
Male Contraceptive Pill / Image: Pixabay

There has been a lot of buzz around the concept of a male birth control in past couple years. A recent Technology Networks article provided new information on the topic noting that the pill passed safety and tolerability tests. The results of the 30-day Phase 1 study, funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, suggests the contraceptive pill will decrease sperm production while leaving the libido intact.

A main concern surrounding the male contraceptive pill is the effect it has on testosterone levels. However, one co-senior investigator said the effects caused by hormonal changes are minimal, and the effects are reversible after stopping treatment. The contraceptive, 11-beta-MNTDC, mimics testosterone in the rest of the body, but isn’t concentrated enough in the testes to support sperm production. The drug takes roughly 60-90 days to actually affect sperm production, so the team is planning longer studies before testing on sexually active couples.

How to Honor a Leader
Induction into the Packaging & Processing Hall of Fame is the highest honor in our industry. Submit your leader to be considered for the Class of 2024 now through June 10th. New members will be inducted at PACK EXPO International in Chicago.
Read More
How to Honor a Leader
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts